BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 13, 2003
View Archived Issues
Omiloxetine characterized as SSRI with potential in depression
Read More
Improvement associated with AC-2592 in advanced heart failure patients
Read More
Beneficial effects of NM-702 in intermittent claudication
Read More
Similar efficacy of CVT-3146 and adenosine in detecting myocardial ischemia
Read More
Two series of complement C5a receptor modulators patented by Neurogen
Read More
Merck claims novel cannabinoid CB1 modulators with utility as antiobesity agents
Read More
New pyridoxal-based HIV integrase inhibitors covered by Pharmacor patent
Read More
AstraZeneca researchers design novel GSK-3 inhibitors for AD therapy
Read More
Japanese team identifies compounds with leukocyte-enhancing and DPP-IV-inhibitory activity
Read More
Novel HIV protease inhibitors prepared and tested at Pharmacor
Read More
Lilly scientists discover new ERbeta agonists for use in prostate cancer
Read More
Rho kinase inhibitors discovered at Sumitomo
Read More
Assessment of the benefits of enfuvirtide in HIV-infected patients
Read More
Good efficacy and safety profile of ocinaplon in GAD
Read More
Efficacy and safety of NO-aspirin demonstrated in mice and in healthy subjects
Read More
Positive preliminary results for AVR-118 in cachexia
Read More
Exenatide meets glucose control endpoint in second of three pivotal trials
Read More
Arpida and Polyphor to discover new antibacterial and antifungal compounds
Read More
Six-month Eligard product completes phase III trial
Read More
Enrollment begins in ASSENT 4 PCI trial
Read More
EpiTan plans IND filing for Melanotan
Read More
Immunomedics negotiating return of epratuzumab rights from Amgen
Read More
Treatment under way in ML's phase II prostate cancer study
Read More
No morning residual effects after middle-of-night administration of indiplon
Read More
Plexxikon supplies novel kinase inhibitor to Genentech
Read More
Completion of first dose level in Oxycyte phase I study
Read More
Grant supports development of Resmycin
Read More
Cognition-enhancing effects demonstrated for selective histamine H3 receptor antagonist
Read More
